These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 12660421

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE, Monasterolo G, Coco G, Operti D.
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Par j 1 and Par j 2, the major allergens from Parietaria judaica pollen, have similar immunoglobulin E epitopes.
    Asturias JA, Gómez-Bayón N, Eseverri JL, Martínez A.
    Clin Exp Allergy; 2003 Apr; 33(4):518-24. PubMed ID: 12680870
    [Abstract] [Full Text] [Related]

  • 7. Assignment of disulphide bridges in Par j 2.0101, a major allergen of Parietaria judaica pollen.
    Amoresano A, Pucci P, Duro G, Colombo P, Costa MA, Izzo V, Lamba D, Geraci D.
    Biol Chem; 2003 Aug; 384(8):1165-72. PubMed ID: 12974385
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Multiple IgE recognition on the major allergen of the Parietaria pollen Par j 2.
    Longo V, Costa MA, Cibella F, Cuttitta G, La Grutta S, Colombo P.
    Mol Immunol; 2015 Feb; 63(2):412-9. PubMed ID: 25284812
    [Abstract] [Full Text] [Related]

  • 10. Identification of cross-reactive and genuine Parietaria judaica pollen allergens.
    Stumvoll S, Westritschnig K, Lidholm J, Spitzauer S, Colombo P, Duro G, Kraft D, Geraci D, Valenta R.
    J Allergy Clin Immunol; 2003 May; 111(5):974-9. PubMed ID: 12743560
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of cross-reactivity between Holoptelea integrifolia and Parietaria judaica.
    Sharma S, Panzani RC, Gaur SN, Ariano R, Singh AB.
    Int Arch Allergy Immunol; 2005 Feb; 136(2):103-12. PubMed ID: 15650307
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characterization of a Par j 1/Par j 2 mutant hybrid with reduced allergenicity for immunotherapy of Parietaria allergy.
    Bonura A, Passantino R, Costa MA, Montana G, Melis M, Bondì ML, Butteroni C, Barletta B, Corinti S, Di Felice G, Colombo P.
    Clin Exp Allergy; 2012 Mar; 42(3):471-80. PubMed ID: 22356145
    [Abstract] [Full Text] [Related]

  • 20. Immunotherapy with a mass unit Parietaria judaica extract: a tolerance study with evidence of immunological changes to the major allergen Par j 1.
    García Villalmanzo I, Hernández MD, Campos A, Giner AM, Polo F, Cortés C, Basomba A.
    J Investig Allergol Clin Immunol; 1999 Mar; 9(5):321-9. PubMed ID: 10582201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.